Pharmaceutical Research

, Volume 12, Issue 3, pp 451–454 | Cite as

Stabilization of Human Epidermal Growth Factor (hEGF) in Aqueous Formulation

  • Kyonghee Son
  • Changhyuk Kwon
Note
epidermal growth factor chemical and physical stability deamidation peptide bond cleavage aggregation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    G. Carpenter and S. Cohen. Epidermal growth factor (EGF). Annu. Rev. Biochem. 48:193–216 (1979).Google Scholar
  2. 2.
    H. Gregory. Isolation and structure of urogastron and its relationship to EGF. Nature 257:325–327 (1975).Google Scholar
  3. 3.
    G. Carpenter and J. G. Zendegui. Epidermal growth factor, its receptor, and related proteins. Exp. Cell Res. 164:1–10 (1986).Google Scholar
  4. 4.
    G. Singh and C. Foster. Epidermal growth factor in alkali-burned corneal epithelial wound healing. Am. J. Ophthal. 103:802–807 (1987).Google Scholar
  5. 5.
    G. Arturson. Epidermal growth factor in the healing of corneal wound, epidermal wound and partial-thickness scalds. Scand. J. Plast. Reconstr. Surg. 18:33–37 (1984).Google Scholar
  6. 6.
    G. L. Brown, L, Curtsinger, J. R. Brightwell, D. M. Ackerman, G. R. Tobin, H. C. Polk, C. George-Nascimento, P. Valenzuela, and G. S. Schultz. Enhancement of epidermal regeneration by biosynthetic EGF. Chiron, wound healing efficacy. J. Exp. Med. 163:1319–1324 (1986).Google Scholar
  7. 7.
    M. C. Manning, K. Patel, and R. T. Borchardt. Stability of protein pharmaceuticals. Pharm. Res. 6:903–918 (1989).Google Scholar
  8. 8.
    A. B. Robinson and C. J. Rudd. Deamidation of glutaminyl and asparaginyl residues in peptides and proteins. Current Topics in Cellular Regulation, vol. 8, Academic Press, New York, 1974, pp. 247–295.Google Scholar
  9. 9.
    T. Geiger and S. Clarke. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262:785–794 (1987).Google Scholar
  10. 10.
    J. W. Scotchler and A. B. Robinson. Deamidation of glutaminyl residues: Dependence on pH, temperature, and ionic strength. Anal. Biochem. 59:319–322 (1974).Google Scholar
  11. 11.
    A. J. Brake, J. P. Merryweather, D. G. Coit, U. A. Heberlein, F. R. Masiarz, G. T. Mullenbach, M. S. Urdea, P. Valenzuela, and P. J. Barr. α-factor-directed synthesis and secretion of mature foreign proteins in saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 81:4642–4646 (1984).Google Scholar
  12. 12.
    W. F. Heath and R. B. Merrifield. A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule. Proc. Natl. Acad. Sci. USA 83:6367–6371 (1986).Google Scholar
  13. 13.
    A. W. Burgess, J. Knesel, L. G. Sparrow, N. A. Nicola and E. C. Nice. Two forms of murine EGF (mEGF): Rapid separation by using reverse phase HPLC (RP-HPLC). Proc. Natl. Acad. Sci. USA 79:5753–5757 (1982).Google Scholar
  14. 14.
    R. P. DiAugustine, M. P. Walker, D. G. Klapper, R. I. Grove, W. D. Willis, D. J. Harvan, and O. Hernandez. β-Epidermal growth factor is the desasparaginyl form of the polypeptide. J. Biol. Chem. 260:2807–2811 (1988).Google Scholar
  15. 15.
    F. Araki, H. Nakamura, N. Nouma, K. Tsukumo, and S. Sakamoto. Stability of recombinant human epidermal growth factor in various solutions. Chem. Pharm. Bull. 37:404–406 (1989).Google Scholar
  16. 16.
    M. W. Riemen, R. J. Wegrzyn, A. E. Baker, W. M. Hurni, C. D. Bennett, A. Oliff, and R. B. Stein. Isolation of multiple biologically and chemically diverse species of epidermal growth factor. Peptides 8:877–885 (1987).Google Scholar
  17. 17.
    A. S. Chawla, I. Hinberg, P. Blais, and D. Johnson. Aggregation of insulin, containing surfactants, in contact with different materials. Diabetes 34:420–424 (1985).Google Scholar
  18. 18.
    A. A. Kossiakoff. Tertiary structure is a principal determinant to protein deamidation. Science 240:191–194 (1988).Google Scholar
  19. 19.
    T. Arakawa and S. N. Timasheff. Stabilization of protein structure by sugars. Biochemistry 21:6536–6544 (1982).Google Scholar
  20. 20.
    J. Brange, L. Langkjaer, S. Havelund and A. Volund. Chemical stability of insuline. 1. Hydrolytic degradation during storage of pharmaceutical preparation. Pharm. Res. 9:715–726 (1992).Google Scholar
  21. 21.
    M. A. Scheinberg, J. R. Wohigethan and E. S. Cathcart. Humoral and cellular aspects of amyloid disease present status. Prog. Allergy 27:250–276 (1980).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Kyonghee Son
    • 1
  • Changhyuk Kwon
    • 1
  1. 1.Daewoong Pharmaceutical Company, LTD.Sungnam CityKorea

Personalised recommendations